MK-677 (Ibutamoren) MK-677 is often grouped with growth hormone secretagogues. Some users report shifts in sleep stages, but responses differ
These benefits are now also evident in people with obesity at high CVD risk (or with known vascular disease) but without T2D, as shown by the favorable effects of semaglutide in the Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity (SELECT) clinical trial 36
It signals your brain and your stomach that you are done eating, providing control of appetite, satiety, and a decrease in stomach peristalsis (pumping)
T.AlaynickW
The significant improvement in CSSS in our series of studied DRE patients on KDT comes in agreement with several previous research
Now with modern technology we can harness those anti-inflammatory effects to provide long term benefits, whether thats a reduction in psoriasis symptoms, decreased risk of cardiovascular disease, possibly less risk of dying from infection and who knows what else